Omega-3 Fatty Acids for Dry Eye Disease: An Updated Systematic Review

Authors

  • Gusti Ayu Ning Wikan Sari Kembangan Regional General Hospital, Jakarta Barat, Indonesia
  • Daniel Atnil Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia
  • Thessia Eflien Pelupessy Masohi Regional General Hospital, Maluku Tengah, Indonesia

DOI:

https://doi.org/10.11594/ojkmi.v7i3.94

Keywords:

dry eye disease, ocular surface, omega-3 fatty acids, supplementation, tear film

Abstract

Introduction: Dry eye disease (DED) is a multifactorial disorder involving tear film instability and ocular surface inflammation. Oral omega-3 fatty acids have been investigated as adjunctive therapy due to their anti-inflammatory and tear-stabilizing effects.

Methods: This systematic review followed PRISMA guidelines and included randomized controlled trials and prospective studies published up to August 2025. Databases searched were PubMed, Scopus, Web of Science, and the Cochrane Library. Primary outcomes were tear break-up time and patient-reported symptoms, with secondary outcomes including Schirmer test results, ocular surface staining, inflammatory markers, and adverse events.

Results: Fifteen studies across various DED subtypes were included. Most reported improvements in tear film stability and symptoms, although two large trials found no significant benefit. Omega-3 supplementation was generally safe, with mild gastrointestinal effects.

Conclusion: Oral omega-3 supplementation is safe and shows moderate efficacy as an adjunctive therapy for dry eye disease, particularly in patients with tear film instability and ocular surface inflammation. Variability in outcomes across studies highlights the need for standardized formulations, optimal dosing regimens, and subgroup-specific recommendations in future trials.

Downloads

Download data is not yet available.

References

Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017 Jul;15(3):334–65. Available from: https://linkinghub.elsevier.com/retrieve/pii/S154201241730109X

Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017 Jul;15(3):276–83. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1542012417301192

Downie LE, Ng SM, Lindsley KB, Akpek EK. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Cochrane Database Syst Rev. 2019 Dec 18. Available from: https://doi.org/10.1002/14651858.CD011016.pub2

O’Byrne C, O’Keeffe M. Omega-3 fatty acids in the management of dry eye disease—An updated systematic review and meta-analysis. Acta Ophthalmol (Copenh). 2023 Mar;101(2). Available from: https://doi.org/10.1111/aos.15255

Wang WX, Ko ML. Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2023 Nov 10;12(22):7026. Available from: https://doi.org/10.3390/jcm12227026

Byrne R. Does omega-3 supplementation improve dry eye symptoms? Evid-Based Pract. 2022 Jan;25(1):37–8. Available from: https://doi.org/10.1097/EBP.0000000000001420

Christen WG, Cook NR, Manson JE, Buring JE, Lee IM, Bubes V, et al. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial. JAMA Ophthalmol. 2022 Jul 1;140(7):707. Available from: https://doi.org/10.1001/jamaophthalmol.2022.2031

Bhargava R, Kumar P. Oral Omega-3 Fatty Acid Treatment for Dry Eye in Contact Lens Wearers. Cornea. 2015 Apr;34(4):413–20. Available from: https://doi.org/10.1097/ICO.0000000000000392

Georgakopoulos CD, Makri OE, Pagoulatos D, Vasilakis P, Peristeropoulou P, Kouli V, et al. Effect of Omega-3 Fatty Acids Dietary Supplementation on Ocular Surface and Tear Film in Diabetic Patients with Dry Eye. J Am Coll Nutr. 2017 Jan 2;36(1):38–43. Available from: https://doi.org/10.1080/07315724.2016.1170643

Hussain M, Shtein RM, Pistilli M, Maguire MG, Oydanich M, Asbell PA. The DREAM extension study – A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease. Ocul Surf. 2020 Jan;18(1):47–55. Available from: https://doi.org/10.1016/j.jtos.2019.08.003

Asbell PA. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med. 2018 May 3;378(18):1681–90. Available from: https://doi.org/10.1056/NEJMoa1709691

Jones L, Downie LE, Korb D, Benitez-del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017 Jul;15(3):575–628. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1542012417301143

Amescua G, Ahmad S, Cheung AY, Choi DS, Jhanji V, Lin A, et al. Dry Eye Syndrome Preferred Practice Pattern®. Ophthalmology. 2024 Apr;131(4):P1–49. Available from: https://doi.org/10.1016/j.ophtha.2023.12.001

Deinema LA, Vingrys AJ, Wong CY, Jackson DC, Chinnery HR, Downie LE. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. Ophthalmology. 2017 Jan;124(1):43–52. Available from: https://doi.org/10.1016/j.ophtha.2016.09.015

Eom Y, Jun I, Jeon HS, Lim DH, Lee H, Hwang HS, et al. Re-Esterified Triglyceride ω-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomized Clinical Trial. JAMA Ophthalmol. 2024 Jul 1;142(7):617. Available from: https://doi.org/10.1001/jamaophthalmol.2024.1816

Park J, Yoo YS, Shin E, Han G, Shin K, Lim DH, et al. Effects of the re-esterified triglyceride (rTG) form of omega-3 supplements on dry eye following cataract surgery. Br J Ophthalmol. 2021 Nov;105(11):1504–9. Available from: https://doi.org/10.1136/bjophthalmol-2020-317164

Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, Prospective, Randomized, Double-masked, Placebo-controlled Clinical Trial of an Omega-3 Supplement for Dry Eye. Cornea. 2011 Mar;30(3):308–14. Available from: https://doi.org/10.1097/ICO.0b013e3181e0c310

Goyal P, Jain AK, Malhotra C. Oral Omega-3 Fatty Acid Supplementation for Laser In Situ Keratomileusis–Associated Dry Eye. Cornea. 2017 Feb;36(2):169–75. Available from: https://doi.org/10.1097/ICO.0000000000001047

Bhargava R, Pandey K, Ranjan S, Mehta B, Malik A. Omega-3 fatty acids supplements for dry eye – Are they effective or ineffective? Indian J Ophthalmol. 2023 Apr;71(4):1619–25. Available from: https://doi.org/10.4103/IJO.IJO_2789_22

Abd Elaleem AE, Ahmed D, Saif M. Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids). Egypt J Med Res. 2022 Apr 1;3(2):196–212. Available from: https://ejmr.journals.ekb.eg/article_240113.html

Roy NS, Yu Y, Ying GS, Maguire MG, Asbell PA, for the DREAM Study Group. Effect of Omega-3 on HLA-DR Expression by Conjunctival Cells and Tear Cytokine Concentrations in the DREAM Study. Eye Contact Lens Sci Clin Pract. 2022 Sep;48(9):384–90. Available from: https://doi.org/10.1097/ICL.0000000000000916

Bhargava R, Chandra M, Bansal U, Singh D, Ranjan S, Sharma S. A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms. Curr Eye Res. 2016 Oct 2;41(10):1274–80. Available from: https://doi.org/10.3109/02713683.2015.1122810

Jo YJ. Effects of dietary high dose DHA omega-3 supplement in dry eye with meibomian gland dysfunction. Int J Ophthalmol. 2021 Nov 18;14(11):1700–6. Available from: http://ies.ijo.cn/gjyken/ch/reader/view_abstract.aspx?file_no=20211108&flag=1

Kangari H, Eftekhari MH, Sardari S, Hashemi H, Salamzadeh J, Ghassemi-Broumand M, et al. Short-term Consumption of Oral Omega-3 and Dry Eye Syndrome. Ophthalmology. 2013 Nov;120(11):2191–6. Available from: https://doi.org/10.1016/j.ophtha.2013.06.009

Kawakita T, Kawabata F, Tsuji T, Kawashima M, Shimmura S, Tsubota K. Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomed Res. 2013;34(5):215–20. Available from: https://doi.org/10.2220/biomedres.34.215

Oleñik A, Jiménez-Alfaro B, Alejandre A, Mahillo-Fernández I. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging. 2013 Aug;8:1133–8. Available from: https://doi.org/10.2147/CIA.S44699

Bhargava R, Kumar P. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol. 2013;6(6):811–5.

Chinnery HR, Naranjo Golborne C, Downie LE. Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. Ophthalmic Physiol Opt. 2017 Jul;37(4):473–81. Available from: https://doi.org/10.1111/opo.12365

Molina-Leyva I, Molina-Leyva A, Riquelme-Gallego B, Cano-Ibáñez N, García-Molina L, Bueno-Cavanillas A. Effectiveness of Mediterranean Diet Implementation in Dry Eye Parameters: A Study of PREDIMED-PLUS Trial. Nutrients. 2020 May 1;12(5):1289. Available from: https://doi.org/10.3390/nu12051289

Markoulli M, Ahmad S, Arcot J, Arita R, Benitez-del-Castillo J, Caffery B, et al. TFOS Lifestyle: Impact of nutrition on the ocular surface. Ocul Surf. 2023 Jul;29:226–71. Available from: https://doi.org/10.1016/j.jtos.2023.03.004

Downloads

Submitted

27-09-2025

Accepted

24-12-2025

Published

31-12-2025

How to Cite

Sari, G. A. N. W., Atnil, D., & Pelupessy, T. E. (2025). Omega-3 Fatty Acids for Dry Eye Disease: An Updated Systematic Review. Oftalmologi Jurnal Kesehatan Mata Indonesia, 7(3). https://doi.org/10.11594/ojkmi.v7i3.94